Which is the appropriate hormone replacement therapy after sub-total hysterectomy?

F. Imoh-Ita, Imoh-Ita F, Morgan P, Peter Morgan, P Morgan, Rymer J, J Rymer, Janice Rymer
Climacteric : the journal of the International Menopause Society · 2000 · vol. 3(1) , pp. 65–67 · doi:10.3109/13697130009167601 · PMID:11910612 · W2146959431
Case report OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-25 ⓘ

This paper examines the appropriate hormone replacement therapy protocols following sub-total hysterectomy, addressing clinical management decisions in the absence of the cervix.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

(2000). Which is the appropriate hormone replacement therapy after sub-total hysterectomy? Climacteric: Vol. 3, No. 1, pp. 65-67.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Estrogen Replacement Therapy Estrogen Replacement Therapy Estrogen Replacement Therapy Hysterectomy Hysterectomy Administration, Cutaneous Administration, Cutaneous Dilatation and Curettage Dilatation and Curettage Endometriosis Endometriosis Endometriosis Estradiol Estradiol Estradiol Estrogens, Conjugated (USP) Estrogens, Conjugated (USP) Estrogens, Conjugated (USP) Fallopian Tubes Fallopian Tubes

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (13)

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:00:24.492322+00:00
unpaywall
last seen: 2026-10-25T06:24:14.523685+00:00
License: CC0 · commercial use OK